Researchers hope that changes to total hip BMD will get approval from the FDA as a surrogate endpoint for clinical trials of investigational anti-osteoporosis drugs.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/what-bmds-impact-surrogate-osteoporosis-endpoint-2025a1000p2b?src=rss
Author :
Publish date : 2025-09-19 21:33:00
Copyright for syndicated content belongs to the linked Source.